November 17 -- Intellectual property restrictions rarely impose burdens on genomic and proteomic research, but there are reasons to be apprehensive about their future impact on advances in this field, says a new report from the National Research Council. Policy-makers should take steps to prevent the increasingly complex web of intellectual property protections from getting in the way of potential biomedical breakthroughs.
Office
of News and Public Information |
|
| Copyright © 2005. National Academy of Sciences. All rights reserved. 500 Fifth St. N.W., Washington, D.C. 20001. | |